EW
AVXL icon

Evoke Wealth’s Anavex Life Sciences AVXL Stock Holding History

Evoke Wealth’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,800
Closed -$39K – 423
2022
Q3 		$39K Hold
3,800
– – ﹤0.01% 552
2022
Q2 		$38K Hold
3,800
– – ﹤0.01% 549
2022
Q1 		$47K Sell
3,800
-136
-3% -$1.67K ﹤0.01% 531
2021
Q4 		$68K Buy
3,936
+136
+4% +$2.58K ﹤0.01% 496
2021
Q3 		$68K Hold
3,800
– – ﹤0.01% 472
2021
Q2 		$87K Hold
3,800
– – ﹤0.01% 458
2021
Q1 		$57K Buy
+3,800
New +$41.5K ﹤0.01% 437

Other funds holding AVXL

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return